These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31416637)

  • 1. An open-label, prospective, randomized, controlled, multicenter, phase 1b study of StrataGraft skin tissue versus autografting in patients with deep partial-thickness thermal burns.
    Holmes JH; Schurr MJ; King BT; Foster K; Faucher LD; Lokuta MA; Comer AR; Rooney PJ; Barbeau KF; Mohoney ST; Gibson ALF; Lynn Allen-Hoffmann B
    Burns; 2019 Dec; 45(8):1749-1758. PubMed ID: 31416637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase 3, open-label, controlled, randomized, multicenter trial evaluating the efficacy and safety of StrataGraft® construct in patients with deep partial-thickness thermal burns.
    Gibson ALF; Holmes JH; Shupp JW; Smith D; Joe V; Carson J; Litt J; Kahn S; Short T; Cancio L; Rizzo J; Carter JE; Foster K; Lokuta MA; Comer AR; Smiell JM; Allen-Hoffmann BL
    Burns; 2021 Aug; 47(5):1024-1037. PubMed ID: 34099322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pooled safety analysis of STRATA2011 and STRATA2016 clinical trials evaluating the use of StrataGraft® in patients with deep partial-thickness thermal burns.
    Holmes Iv JH; Cancio LC; Carter JE; Faucher LD; Foster K; Hahn HD; King BT; Rutan R; Smiell JM; Wu R; Gibson ALF
    Burns; 2022 Dec; 48(8):1816-1824. PubMed ID: 35941023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I/II clinical evaluation of StrataGraft: a consistent, pathogen-free human skin substitute.
    Schurr MJ; Foster KN; Centanni JM; Comer AR; Wicks A; Gibson AL; Thomas-Virnig CL; Schlosser SJ; Faucher LD; Lokuta MA; Allen-Hoffmann BL
    J Trauma; 2009 Mar; 66(3):866-73; discussion 873-4. PubMed ID: 19276766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial.
    Centanni JM; Straseski JA; Wicks A; Hank JA; Rasmussen CA; Lokuta MA; Schurr MJ; Foster KN; Faucher LD; Caruso DM; Comer AR; Allen-Hoffmann BL
    Ann Surg; 2011 Apr; 253(4):672-83. PubMed ID: 21475006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of Burns Treated With Autologous Cultured Proliferating Epidermal Cells: A Prospective Randomized Multicenter Intrapatient Comparative Trial.
    Gardien KL; Marck RE; Bloemen MC; Waaijman T; Gibbs S; Ulrich MM; Middelkoop E;
    Cell Transplant; 2016; 25(3):437-48. PubMed ID: 26419871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of the safety and effectiveness of the RECELL
    Holmes JH; Molnar JA; Shupp JW; Hickerson WL; King BT; Foster KN; Cairns BA; Carter JE
    Burns; 2019 Jun; 45(4):772-782. PubMed ID: 30578048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic debridement of deeply burned faces: Healing and early scarring based on tissue preservation compared to traditional surgical debridement.
    Schulz A; Fuchs PC; Rothermundt I; Hoffmann A; Rosenberg L; Shoham Y; Oberländer H; Schiefer J
    Burns; 2017 Sep; 43(6):1233-1243. PubMed ID: 28363663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-spray auto-grafting technology for deep partial-thickness burns: Problems and solutions during clinical implementation.
    Esteban-Vives R; Corcos A; Choi MS; Young MT; Over P; Ziembicki J; Gerlach JC
    Burns; 2018 May; 44(3):549-559. PubMed ID: 29183637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical assessment of safety and efficacy of intravenous delivery of autologous adipose-derived regenerative cells (ADRCs) in the treatment of severe thermal burns using a porcine model.
    Foubert P; Liu M; Anderson S; Rajoria R; Gutierrez D; Zafra D; Tenenhaus M; Fraser JK
    Burns; 2018 Sep; 44(6):1531-1542. PubMed ID: 29958745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated Wound Closure of Deep Partial Thickness Burns with Acellular Fish Skin Graft.
    Stone R; Saathoff EC; Larson DA; Wall JT; Wienandt NA; Magnusson S; Kjartansson H; Natesan S; Christy RJ
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of platelet-rich plasma in the treatment of deep dermal burns: A randomized, double-blind, intra-patient controlled study.
    Marck RE; Gardien KL; Stekelenburg CM; Vehmeijer M; Baas D; Tuinebreijer WE; Breederveld RS; Middelkoop E
    Wound Repair Regen; 2016 Jul; 24(4):712-20. PubMed ID: 27169627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the cultured epidermal autograft "JACE(®") for treatment of severe burns: Results of a 6-year multicenter surveillance in Japan.
    Matsumura H; Matsushima A; Ueyama M; Kumagai N
    Burns; 2016 Jun; 42(4):769-76. PubMed ID: 26948957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of Suprathel(®) in deep dermal burns: first results of a prospective study.
    Keck M; Selig HF; Lumenta DB; Kamolz LP; Mittlböck M; Frey M
    Burns; 2012 May; 38(3):388-95. PubMed ID: 22078803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, Paired-Site Comparison of Autologous Engineered Skin Substitutes and Split-Thickness Skin Graft for Closure of Extensive, Full-Thickness Burns.
    Boyce ST; Simpson PS; Rieman MT; Warner PM; Yakuboff KP; Bailey JK; Nelson JK; Fowler LA; Kagan RJ
    J Burn Care Res; 2017; 38(2):61-70. PubMed ID: 27404165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of negative-pressure wound therapy in the management of burn wounds.
    Kantak NA; Mistry R; Halvorson EG
    Burns; 2016 Dec; 42(8):1623-1633. PubMed ID: 27378361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated re-epithelialization of partial-thickness skin wounds by a topical betulin gel: Results of a randomized phase III clinical trials program.
    Barret JP; Podmelle F; Lipový B; Rennekampff HO; Schumann H; Schwieger-Briel A; Zahn TR; Metelmann HR;
    Burns; 2017 Sep; 43(6):1284-1294. PubMed ID: 28400148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of high-frequency ultrasound in dermabrasion of patients with deep partial-thickness burns].
    Zang CY; Cao YQ; Xue WJ; Zhao R; Zhang M; Zhang YH; Feng Z; Wang YB
    Zhonghua Shao Shang Za Zhi; 2017 Feb; 33(2):97-102. PubMed ID: 28219142
    [No Abstract]   [Full Text] [Related]  

  • 19. Flaminal® versus Flamazine® in the treatment of partial thickness burns: A randomized controlled trial on clinical effectiveness and scar quality (FLAM study).
    Rashaan ZM; Krijnen P; Kwa KAA; van der Vlies CH; Schipper IB; Breederveld RS
    Wound Repair Regen; 2019 May; 27(3):257-267. PubMed ID: 30675745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a Gel Containing Polihexanide and Betaine in Deep Partial and Full Thickness Burns Requiring Split-thickness Skin Grafts: A Noncomparative Clinical Study.
    Kiefer J; Harati K; Müller-Seubert W; Fischer S; Ziegler B; Behr B; Gille J; Kneser U; Lehnhardt M; Daigeler A; Dragu A
    J Burn Care Res; 2018 Aug; 39(5):685-693. PubMed ID: 29668985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.